Aclarion, Inc. (ACON) income statement
ACONNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACONW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$1.34−0.03 (-2.19%)
Close on Nov 18, 2026Market cap $3.86MP/E –Yield –
Aclarion, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 21.8%
- Operating margin
- -11592.1%
- Net margin
- -10978.5%
- Return on equity, FY2025
- -104.8%
Financial strength
- Current ratio
- 16.20
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 1570.5%
Valuation
- P/E ratio
- –
- Price to sales
- 46.11
- Price to book
- 0.23
- Dividend yield
- –
See a number that looks wrong?